- November 24, 2020
Yale GIM Fall Retreat Develops CHAMPions to Care for Patients Who Use Substances
- November 05, 2020Source: Cancer Prevention Research
Clearing the Haze: What Do We Still Need to Learn About Electronic Nicotine Delivery Systems?
- November 03, 2020
New App Would Support Those Struggling with Alcohol and Opioid Use
- November 01, 2020Source: ACP Internist
‘Gold standard’ underused for substance misuse
- October 29, 2020Source: Yale Medicine
Liver Disease and Alcohol: Is Binge Drinking To Blame?
- October 22, 2020Source: JAMA Network Open
Yale Study: Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017
Yale Program in Addiction Medicine
The goal of the Yale Program in Addiction Medicine is to expand access to and improve the effectiveness of prevention and treatment services for substance use. We focus on research, education, prevention, and treatment. We study the science of addiction and develop strategies that can be implemented in general medical settings, such as community physicians’ offices, emergency departments, and primary care facilities. Additionally, we offer state of the art training opportunities for a variety of learners to gain knowledge and experience in addiction medicine.
Built on 30 years of pioneering research, Yale’s Program in Addiction Medicine is internationally recognized. Known for developing innovative treatment models, training programs and attracting leaders in the field, Yale’s model programs have been replicated nationally and internationally.
Twitter Feed
@YaleADMRecently published in @DrugAlcoholDep, McGinnis et al examine whether behavioral health & medication treatments for #alcohol use disorder among patients with #HIV were associated with changes in HIV-related outcomes. Read more: https://t.co/pUykwrSDpN https://t.co/G86ZV7bHLH15 HOURS AGO
@YaleADMHomelessness & #opioid use disorder are important public health issues, yet few studies have examined their cooccurrence. Gaeta et al evaluate correlates of homelessness among patients enrolled in low-barrier #methadone treatment programs for OUD. https://t.co/moghSZ6GAC https://t.co/MGu6ZMxIlvA DAY AGO
@YaleADMNewly published, Iloglu et al examine how expansion of #methadone to FQHCs and chain pharmacies in #Ohio may meet the urban & rural need for #opioid use disorder treatment. @PaulJoudreyMD @ewang422 @gregggonsalves
https://t.co/xe2DRvIj75 https://t.co/CEKRh1GS6T3 DAYS AGO
